MMP-9

Testing at point of care for improved patient satisfaction, re-treatment ratesAfter spending a few months testing for dry eye and treating the tear film before doing preoperative measurements, the re-treatment rate dropped from 11% to 3%.
Targeting dry eye in glaucoma patients
Targeting dry eye in glaucoma patientsA poor ocular surface is a common condition in glaucoma patients due to the incidence of dry eye, age, and use of benzalkonium chloride (BAK). Poor compliance with glaucoma therapy can result. Use of point-of-care testing can help identify patients with a poor ocular surface and drive treatment decisions. Treatment options, including surgical, are discussed.
Numbers transform dry eye treatment for symptomatic, asymptomatic patientsAdding objective point-of-care dry eye diagnostics to your practice has deep, measurable effects, including more accurate and consistent IOL power calculations.
In-office lab testing provides diagnostic informationSimilar to the benefits that the primary care and pediatrics fields have enjoyed following years of rapid strep and flu testing, the uptake of rapid, single-use, point-of-care (POC) testing in optometry helps to guide clinical management and therapeutic decisions.
Cataract surgery for patients with PXFMom has pseudoexfoliation syndrome (PXF) clinically visible in both eyes. She experiences pops of elevated intraocular pressure (IOP) in one eye and uses glaucoma medications.
Natural oral omega-3 supplement improves dry eye parameters in 3 monthsThe natural triglyceride form of omega-3 is an excellent treatment option for dry eye disease.